Verena Krähling

3.7k total citations
33 papers, 799 citations indexed

About

Verena Krähling is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Verena Krähling has authored 33 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 10 papers in Epidemiology and 3 papers in Cell Biology. Recurrent topics in Verena Krähling's work include Viral Infections and Outbreaks Research (25 papers), Viral Infections and Vectors (17 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Verena Krähling is often cited by papers focused on Viral Infections and Outbreaks Research (25 papers), Viral Infections and Vectors (17 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Verena Krähling collaborates with scholars based in Germany, United States and United Kingdom. Verena Krähling's co-authors include Elke Mühlberger, Stephan Becker, Judith Olejnik, Michael Schümann, David A. Stein, Friedemann Weber, Martin Spiegel, Osvaldo Martinez, Charalampos Valmas and Sonja M. Best and has published in prestigious journals such as Nature Medicine, Bioinformatics and Journal of Virology.

In The Last Decade

Verena Krähling

31 papers receiving 779 citations

Peers

Verena Krähling
Catherine L. Hunt United States
Masfique Mehedi United States
Shuǐqìng Yú United States
Emily M. Deal United States
Kathrina Quinn United States
Derron A. Alves United States
Erik Dietzel Germany
Courtney Woolsey United States
Catherine L. Hunt United States
Verena Krähling
Citations per year, relative to Verena Krähling Verena Krähling (= 1×) peers Catherine L. Hunt

Countries citing papers authored by Verena Krähling

Since Specialization
Citations

This map shows the geographic impact of Verena Krähling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Krähling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Krähling more than expected).

Fields of papers citing papers by Verena Krähling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Krähling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Krähling. The network helps show where Verena Krähling may publish in the future.

Co-authorship network of co-authors of Verena Krähling

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Krähling. A scholar is included among the top collaborators of Verena Krähling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Krähling. Verena Krähling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kupke, Alexandra, Cornelius Rohde, Sylvia Jany, et al.. (2024). Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans. Vaccines. 12(12). 1316–1316. 2 indexed citations
3.
Pich, Dagmar, Verena Krähling, Stephan Becker, et al.. (2023). SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests. Biomedicines. 11(11). 2892–2892.
4.
Pich, Dagmar, Manuel Albanese, Paul R. Wratil, et al.. (2022). Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. PNAS Nexus. 1(2). 5 indexed citations
5.
Kupke, Alexandra, Asisa Volz, Erik Dietzel, et al.. (2022). Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines. 10(4). 533–533. 10 indexed citations
6.
Rohde, Cornelius, et al.. (2022). Ebola Virus Activates IRE1α-Dependent XBP1u Splicing. Viruses. 15(1). 122–122. 3 indexed citations
7.
Krähling, Verena, Stephanie Erbar, Alexandra Kupke, et al.. (2022). Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection. Molecular Therapy. 31(2). 374–386. 12 indexed citations
8.
Krähling, Verena, Sandro Halwe, Cornelius Rohde, et al.. (2021). Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies. Journal of Immunological Methods. 490. 112958–112958. 31 indexed citations
9.
Müller-Kräuter, Helena, Sarah Katharina Fehling, Richard A. Urbanowicz, et al.. (2020). Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity. npj Vaccines. 5(1). 71–71. 23 indexed citations
10.
Zehner, Matthias, Verena Krähling, Hadas Cohen‐Dvashi, et al.. (2019). Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nature Medicine. 25(10). 1589–1600. 65 indexed citations
11.
Sawatsky, Bevan, Olga Dolnik, Erik Dietzel, et al.. (2018). Generation of therapeutic antisera for emerging viral infections. npj Vaccines. 3(1). 42–42. 6 indexed citations
13.
Dowall, Stuart, Antra Zeltina, Ibrahim Al‐Abdulla, et al.. (2015). Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. The Journal of Infectious Diseases. 213(7). 1124–1133. 20 indexed citations
14.
Krähling, Verena, Cornelius Rohde, Markus Eickmann, et al.. (2015). Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Medical Microbiology and Immunology. 205(2). 173–183. 28 indexed citations
15.
Schmidt, Kristina M., Michael Schümann, Judith Olejnik, Verena Krähling, & Elke Mühlberger. (2011). Recombinant Marburg Virus Expressing EGFP Allows Rapid Screening of Virus Growth and Real-time Visualization of Virus Spread. The Journal of Infectious Diseases. 204(suppl_3). S861–S870. 19 indexed citations
16.
Bharat, Tanmay A. M., James D. Riches, Larissa Kolesnikova, et al.. (2011). Cryo-Electron Tomography of Marburg Virus Particles and Their Morphogenesis within Infected Cells. PLoS Biology. 9(11). e1001196–e1001196. 1 indexed citations
17.
Valmas, Charalampos, Michael Schümann, Judith Olejnik, et al.. (2010). Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus. PLoS Pathogens. 6(1). e1000721–e1000721. 138 indexed citations
18.
Krähling, Verena, Olga Dolnik, Larissa Kolesnikova, et al.. (2010). Establishment of Fruit Bat Cells (Rousettus aegyptiacus) as a Model System for the Investigation of Filoviral Infection. PLoS neglected tropical diseases. 4(8). e802–e802. 46 indexed citations
19.
Welsch, Sonja, Larissa Kolesnikova, Verena Krähling, et al.. (2010). Electron Tomography Reveals the Steps in Filovirus Budding. PLoS Pathogens. 6(4). e1000875–e1000875. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026